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ABSTRACT 
 
Nanoparticles are exceptional in that their physical and chemical properties enable many promising 
medicinal applications. It is widely accepted that nanoparticles should be thoroughly tested for health hazards 
or nanotoxicity. The purpose of this study was to assess in vitro cytotoxicity of Gadolinium oxide nanoparticles 
in  Human melanoma Cell Line. The effects of  magnetic nanoparticles on this cell were evaluated by light 
microscopy and by standard cytotoxicity assays. Our results demonstrate a concentration-dependent toxicity 
for all types of particles tested. Our results suggest that this cell lines provides valuable models to assess the 
cytotoxicity of nanoparticles in human melanoma Cell Line in vitro. 
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INTRODUCTION 
 
Nanotechnology involves the design and management of materials at the nanoscale level to create 
distinctive products that develop novel properties. [1] Bionanomaterials, which are by deﬁnition in the 1–100 
nm range, have been used to create materials that have novel physical/chemical properties and functions 
based on their advantageous, miniscule size. [2,3] Nanoparticles have been planned for the treatment and 
diagnosis of many diseases that need constant drug concentration in the blood or drug targeting to speciﬁc 
cells or organs. [4,5] 
 
The development of suitable magnetic resonance molecular imaging (MRMI) contrast agents is, 
therefore, a very important and absorbing field of research. If formulated properly with other materials, 
nanomaterials may provide greater stability and efﬁciency for propellant systems.[6] Despite the wide 
application of nanomaterials, there is a serious lack of information concerning the impact of manufactured 
nanomaterials on human health. [7] Typically, after systemic administration, the nanoparticles are small 
enough to penetrate even very small capillaries throughout the body, and therefore they offer the most 
effective approach to distribution in certain tissues. Because nano- particles can pass through biological 
membranes, they can affect the physiology of any cell in an animal body. [8,9] This study would be involved 
with nanoparticles composed gadolinium (III) oxide (Gd2O3) with diethylene glycol polymer. Gd2O3 
nanoparticles  with Diethylene Glycol Polymer could produce a good MR signal and therefore could be a useful 
potential contrast medium for cell tracking in magnetic resonance molecular imaging(MRMI). [10] In this study, 
Gd2O3 nanoparticles  were used as a model nanomaterial for the evaluation of invitro potential toxicity. The 
purpose of this study was to assess in vitro cytotoxicity of Gd2O3 nanoparticles in Human melanoma Cell Line 
as models to assess nanotoxicity invitro. The effects of nanoparticle on this cell was evaluated using light 
microscopy and by standard cytotoxicity assays.  
 
EXPERIMENTAL 
 
Synthesis of Gd2O3 Nanoparticles 
 
Gadolinium oxide nanoparticles were synthesized by the polyol method started from Gd2O3 reacting 
with HCl and resulting to GdCl36H2O ( 2.5 mmol) was dissolved in 12.5 ml DEG (diethylene glycol) by heating 
the mixture to 140 C. Solid NaOH (3.125mmol) was dissolved in 12.5 ml DEG and subsequently added to the 
Gd containing solution. The temperature of the mixture was raised to 180  C and held constant for 4 h under 
reﬂux and magnetic stirring yielding a colloid. The concentrations for samples were 0.1, 0.3, 0.6, 0.9, 1.2 ,1.5, 
1.8 and 2.5 mM and the volume for each sample was 5 ml. The size and morphological structure of this Nano 
particle determined by particle size analysis device(zeta sizer) and Transmission Electronic Microscope(TEM). 
 
Cell Line 
 
The SK-MEL-3(Human skin, malignant melanoma, cell line obtained from National Cell Bank of Iran, 
Pasteure Institute of Iran were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum 
(FBS), 0.03% L-Glutamine and 1% penicillin/streptomycin (Gibco-BRL, MD, USA) at 37C in a 5% CO2 
atmosphere.  
 
Microculture tetrazolium test (MTT assay) 
 
The inhibitory effect of Gd2O3 on growth and proliferation of SKMEL-3 cell line was assessed at uptake 
of thiazolyl blue tetrazolium bromide (MTT, Sigma) by viable cells. [11] Cells were plated on to 96-well plates 
(Orange    Scientific, Brussels, Belgium) at a density of 1.5 x 10
4
 cell/100µl/well. After incubation at 37°C for 24 
h, the medium was replaced with either control medium or medium containing specialized concentration 
Gd2O3 for 2, 8 and 24 h. The concentration of Gd2O3 for cell culture treatment was 0.1, 0.3, 0.6, 0.9, 1.2, 1.5, 
1.8, 2.5 mM respectively and the concentration of zero means negative control. 50 µl of MTT solution (0.5 
mg/ml) was added to each well and then cells incubated at 37C for 3 h. Following solubilization of 
precipitated formazan with 100 µl DMSO, the optical densitometry was measured at a wavelength of 570 nm. 
The inhibition rate (IR) was evaluated using the following equation: IR (%) = 1- ODexp/ODcon ×100, where ODexp 
and ODcon are the optical densitometries of treated and untreated cells, respectively. The viability rate of 
Gd2O3 was evaluated using the following equation: Viability (%) = 100 - IR (%). [12] 
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LDH leakage 
 
LDH assay was performed for detection of cytotoxicity index of Gd2O3-DEG in the cell medium by 
using a commercially available kit (Roche Applied Science).  
 
Serum Lactate Dehydrogenase (LDH) Assay-Serum stored at 20 °C was used for this assay, [2] which 
was performed according to the manufacturer’s protocol (Roche Applied Science). Briefly, after the exposure 
of SKMEL-3 cell line to and Gd2O3-DEG for 2 h, 100 µl of supernantant was transferred into an optically clear 
96-well flat-bottomed microtiter plate. The concentration of Gd2O3 for cell culture treatment was 0.1, 0.3, 0.9, 
1.5, 2.5 mM respectively and the concentration of zero means negative control. To determine LDH activity, 100 
µl of reaction mixture was added to each well and incubated for 30 min at 15–25 °C. Control group is %0.1 
DMSO (Dimethyl sulfoxide).  The spectrophotometer was calibrated to zero absorbance using culture medium 
without cells. The relative LDH leakage (%) related to control wells containing cell culture medium without 
nanoparticles or PBS as a vehicle was calculated by [A] test/[A] control×100. 
 
Where [A]test is the absorbance of the test sample and [A] control is the absorbance of the control 
sample. The absorbance of the samples was measured at 490 nm using an ELISA reader. Released LDH in 
culture supernatants results in the conversion of a tetrazolium salt (INT) into a red formazan product. The 
amount of color formed is proportional to the number of lysed cells.  Cytotoxicity is expressed relative to the 
basal LDH release by untreated control cells. 
 
In addition, cell viability after incubation with Gd2O3–DEG was studied with trypan blue. Incubation 
concentrations used were 0.5 and 2.5 mM and cells were dyed with trypan blue and counted in a Burker 
chamber. One set of samples was washed after 2 h of incubation and one set of samples was kept unwashed. 
The cell samples were then kept in culture for 8 days and viability was monitored directly after 2 h of 
incubation and after 24h. [13] 
 
Atomic absorption spectroscopy (AAS) assay 
 
At the end of Gd NP exposure, cells were washed twice in PBS, trypsinized, spun down and 
resuspended in nitric acid (69%). Cells were lysed at room temperature by sonication for 15 min in a water 
bath and allowed to digest for 1 h. Finally, samples were centrifuged at 5,000×g for 2 min to eliminate debris. 
Supernatants were diluted to a final concentration of 5% HNO  and AAS was performed as described above. 
 
Side scatter measurements 
 
After Gd NP exposure, cells were trypsinized, centrifuged and resuspended in PBS. The light side 
scatter intensity was measured by flowcytometry (Quanta SC MPL, Beckman Coulter). Cellular debris was 
gated out, and the mean side scatter was recorded by the Quanta SC MPL Analysis software based on 20,000 
events. 
 
Statistical analysis 
 
All data were presented as mean ± standard deviation (SD). Student’s t-test for means comparison of 
two samples was carried out. Statistical signiﬁcance was ascertained when p value was less than 0.05. 
 
 
RESULTS 
 
Characterisation Test: For particle size determination; particle size analysis device(zeta sizer) showed 
Gd2O3nanoparticles to be 30 nm, Fig.1(A), Meanwhile, the size and morphological structure of the nanoparticle 
also determined by Transmission Electronic Microscope(TEM)(A902 TEM CEM model), Fig.1(B).  
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(A)                                                      
 
  (B) 
Figure 1(A): Size measurement of the Gd2O3-DEG and (B): TEM photomicrograph of a single gadolinium nanoparticle. 
 
Cell Morphology 
 
              The general morphology of the cell  incubated with nanoparticles in phase-contrast microscopy is 
shown in Figure 2. 
 
 
(A)                         (B)                         (C) 
 
(D) 
 
Figure 2:  Morphology of the cells (A) SK-MEL-3control cell (B) SK-MEL-3 cells after incubation with Gd2O3DEG for 2 h (C) 
SK-MEL-3 cells after incubation with Gd2O3-DEG for 8 h (D) SK-MEL-3 cells after incubation with Gd2O3-DEG for 24h. 
 
              The ﬁg2.B,C,D  show  that the cells were well spread, and there was no distinct change in morphology 
after 2, 8, 24 h of incubation with Gd
2
O
3
-DEG  nanoparticles relative.  
 
Gd NP uptake 
 
It has been proposed that the intracellular concentration of NPs is reflected in the intensity of light 
side scatter measured by flow cytometry. [14] Using this experimental approach, a dose dependent increase in 
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cellular uptake of Gd NPs was detected at doses from 5 to 10µg/ml after 24-h NP exposure (Fig. 3a). A similar 
dose-dependent increase in side scatter was detected when the cells had been pretreated by NAC for 1 h, 
suggesting that the increased cellular granularity is not an artifact caused by dying cells.To further verify the 
uptake of Gd in SKMEL-3cells at different time points and doses, AAS analyses were employed (Fig. 3b). Gd 
could not be detected in controls and cells exposed to Gd NP for 1 min. However, at 4 and 24 h, a dose- and 
time-dependent accumulation of Gd could be measured in SKMEL-3 cell lysates. 
 
 
 
Figure 3: Gd NP uptake (A) Cells were pretreated for 1 h in media ± NAC (10 mM) and exposed to different 
concentrations of Gd NPs for 24 h. After exposure, the cells were assayed for light side scatter intensity by 
flowcytometry (B) Cells were treated with Gd NPs at different time points, and the Gd concentration of cell lysates was 
determined by AAS. The data are expressed as mean ±SD of three independent experiments. Asterisks denote significant 
(p <0.05) difference from the untreated control. ND = not detectable. 
 
Microculture tetrazolium test (MTT assay) 
 
The mitochondrial function  of the cells was measured by means of the MTT assay after culturing in 
presence of the nanoparticles for 2, 8 and 24 h. As is evident from Figure 4, the gadolinium(III) oxide(Gd2O3) 
nanoparticles  with diethylene glycol polymer (DEG) had no signiﬁcant effect.  
 
 
(A) 
 
 
(B) 
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(C) 
 
Figure 4: viability of SK-MEL-3cells (A) after 2hr incubation with Gd2O3-DEG (B)  after 8hr incubation with Gd2O3-DEG (C) 
after 24hr incubation with Gd2O3-DEG . 
 
LDH leakage 
 
Fig5 shows that soluble Gd2O3-DEG have no effect on the plasma membrane at any of the 
concentrations tested.  
 
Viability with trypan blue observations showed that incubation with Gd2O3-DEG for 2 h did not affect cell line. 
Neither washed samples nor samples where Gd2O3was left in the culture were affected in any signiﬁcant way.  
 
 
 
Figure 5:  LDH membrane leakage in presence of different  concentrations  of Gd2O3 nanoparticle. 
 
DISCUSSION 
 
Magnetic resonance imaging (MRI) is an really important imaging modality because it does not 
employ ionising radiation, has excellent spatial resolution and can be used to image wide areas of interest. Its 
usefulness can be enhanced further by using contrast agents with magnetic susceptibility. Gadolinium (Gd) is 
currently the most common MRI contrast agent. For MRI to compete with, and to be superior, molecular 
imaging techniques such as positron emission tomography (PET) and single photon emission computed 
tomography (SPECT), special contrast agents consisting of nanometer-scale particles carrying high delivering of 
gadolinium will be needed. The development of suitable magnetic resonance molecular imaging (MRMI) 
contrast agents is, therefore, a very important and absorbing field of research. [15,16] 
 
Gadolinium (Gd) is a well known paramagnetic contrast agent the natural toxicity of which is 
conventionally counteracted by using it in a chelated form such as diethylenetriamine pentaacetic acid (Gd-
DTPA) or tetraazacyclododecanetetraacetic acid  ( Gd-DOTA). [17] 
 
Magnetic nanoparticle probes are emerging as a class of novel contrast and tracking agents for 
medical imaging. When used as a contrast agent for magnetic resonance imaging (MRI), allow researchers and 
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clinicians to enhance the tissue contrast of an area of interest by increasing the relaxation rate of water. [18-
23]. 
 
Development of an ideal paramagnetic nanoparticle-based contrast agent is a 'hot topic' in current 
research focused on making MRMI a clinically feasible and superior form of diagnostic molecular imaging. 
Paramagnetic nanoparticles such as gadolinium have the potential to greatly enhance the sensitivity, and 
therefore clinical usefulness, of MRI by enabling imaging at cellular and subcellular levels. [24-29, 10] This 
study would be involved with nanoparticles composed gadolinium (III) oxide (Gd2O3) with diethylene glycol 
polymer. 
 
In this study, we used SKMEL-3 cell line to evaluate the toxicity of Gd2O3nanoparticles. However, TEM 
is a time consuming qualitative method for determining NP uptake. Accordingly, we used the light side scatter 
(granularity)of NP-exposed cells to demonstrate Ag NP uptake [14] which was verified by AAS measurements 
on cell lysates. 
 
We used parameters widely used in toxicological studies, such as the ability of mitochondria to reduce 
MTT, the integrity of the plasma membrane. [30, 31] 
 
The proliferation/viability of Gd2O3 nanoparticles was measured by MTT assay after culturing for 2, 8 
and 24 hours. As it is evident from fig.2, After 24 hours, cell line was found to be more than 100% viable 
relative to control cells at Gd2O3-DEG  nanoparticles. Toxicity of Gd2O3-DEG nanoparticles was sufficiently low 
since no significant decrease in cell viability was observed in cells interacting with nanoparticles for prolonged 
periods. 
 
CONCLUSIONS 
 
The results from the MTT assay and LDH assay suggest that the Gd2O3-DEG  nanoparticles are non-
toxic to cells and do not cause any apparent harm to cells. Our results suggest that this cell lines provides  
valuable models to assess the cytotoxicity of nanoparticles in vitro. 
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